PMC8627137_01
solid pseudopapillary neoplasm; pseudo-papillary component with vessels surrounded by loosely cohesive cells
PAMJ-40-110-g001.jpg
PMC8627137_02_PAMJ-40-110-g001.jpg
F1
It has a papillary architecture (Figure 1, Figure 2) in the center surrounded with massive structures at the periphery.
solid pseudopapillary neoplasm; cystic pattern with large hemorrhagic changes and foamy cells
PAMJ-40-110-g002.jpg
PMC8627137_02_PAMJ-40-110-g002.jpg
F2
It has a papillary architecture (Figure 1, Figure 2) in the center surrounded with massive structures at the periphery.
solid pseudopapillary neoplasm; the neoplastic cells show nuclear immunolabelling for beta-catenin
PAMJ-40-110-g003.jpg
PMC8627137_02_PAMJ-40-110-g003.jpg
F3
They showed nuclear staining with beta-catenin (Figure 3).
solid pseudopapillary neoplasm; diffuse intracytoplasmic dot-like imunoreactivity for CD99
PAMJ-40-110-g004.jpg
PMC8627137_02_PAMJ-40-110-g004.jpg
F4
Cells was positive for CD99 with diffuse and in dot expression (Figure 4).
PMC8627137_02
solid pseudopapillary neoplasm; pseudo-papillary component with vessels surrounded by loosely cohesive cells
PAMJ-40-110-g001.jpg
PMC8627137_02_PAMJ-40-110-g001.jpg
F1
It has a papillary architecture (Figure 1, Figure 2) in the center surrounded with massive structures at the periphery.
solid pseudopapillary neoplasm; cystic pattern with large hemorrhagic changes and foamy cells
PAMJ-40-110-g002.jpg
PMC8627137_02_PAMJ-40-110-g002.jpg
F2
It has a papillary architecture (Figure 1, Figure 2) in the center surrounded with massive structures at the periphery.
solid pseudopapillary neoplasm; the neoplastic cells show nuclear immunolabelling for beta-catenin
PAMJ-40-110-g003.jpg
PMC8627137_02_PAMJ-40-110-g003.jpg
F3
They showed nuclear staining with beta-catenin (Figure 3).
solid pseudopapillary neoplasm; diffuse intracytoplasmic dot-like imunoreactivity for CD99
PAMJ-40-110-g004.jpg
PMC8627137_02_PAMJ-40-110-g004.jpg
F4
Cells was positive for CD99 with diffuse and in dot expression (Figure 4).